Pharma Solutions Bangladesh Limited (PSBL), formerly Zuellig Pharma Bangladesh Limited (ZPBL), was incorporated in Bangladesh in 2006 to support multinational pharmaceutical companies in leveraging emerging opportunities in the country’s healthcare sector. The company commenced operations in February 2007 as a subsidiary of Zuellig Pharma Asia Pacific, with 100% ownership under Zuellig Pharma Holdings Limited.
In 2007, GlaxoSmithKline (GSK) partnered with ZPBL as its distribution associate in Bangladesh. In the following years, the distribution businesses of RAK Pharmaceuticals, Reckitt Benckiser, Novartis Bangladesh Limited, Sandoz, Elanco, Roche Diabetes Care, Menarini, Omron Healthcare, Marie Stopes and Sebamed were integrated into the company’s operations, enabling PSBL to develop strong expertise in pharmaceutical warehousing, distribution, and supply chain management for global healthcare companies.
In 2015, ZPBL separated from the Zuellig group and was subsequently acquired by Rapid Keen Holdings Limited. In mid-2019, the company was rebranded as Pharma Solutions Bangladesh Limited (PSBL), marking a new phase of growth and operational expansion in Bangladesh’s healthcare supply chain sector.
Today, PSBL provides advanced warehousing, distribution, supply chain management, and value-added logistics services to pharmaceutical and healthcare manufacturers. The company currently partners with organizations including :
- Albion Laboratories Limited
- Bengal Remedies Limited
- Bengal Overseas Limited
- DBL Healthcare Ltd.
- DBL Pharmaceuticals Ltd.
- EON Group
- Godrej Household Products BD.
- Novivo Healthcare Limited
- Pharma & Pharm
- Pharmasia Ltd.
- UNIDO Pharmaceuticals Ltd.
- Yelanc Pharma
- JMI Hospital Requisite Manufacturing Ltd.
- Mundipharma Bangladesh Private Limited
- Quantam Pharma Limited
- HALEON
- AG‑NOBLE Bangladesh Limited.
In addition to its current partnerships, PSBL has extensive experience working with leading global pharmaceutical companies such as GlaxoSmithKline (GSK), Novartis, and RAK Pharmaceuticals, further strengthening its expertise in multinational healthcare supply chain operations.
As of 2022, PSBL held approximately 61% of the multinational pharmaceutical distribution market in Bangladesh, representing around 4% of the total pharmaceutical market, with annual sales exceeding USD 90 million. The company serves more than 70,000 customers across multiple healthcare channels, including doctors, hospitals, pharmacies, clinics, and wholesalers.
With significant investments in modern warehousing infrastructure and logistics capabilities, PSBL ensures a seamless and compliant supply chain process that guarantees the safe storage, handling, and distribution of healthcare products throughout the entire value chain.